期刊文献+

血吸虫病并结肠癌ING1、p53、bcl-2基因表达的研究 被引量:3

Expression of ING1、p53、bcl-2 in Carcinoma of Colon with Schistosomiasis
下载PDF
导出
摘要 目的探讨血吸虫病并结肠癌与ING1、p53、bcl-2基因之间的相关性及其可能的作用机制。方法采用免疫组化Envision法检测血吸虫病并结肠癌62例、无血吸虫病56例结肠癌中的ING1、p53、bcl-2的表达。结果在血吸虫病并结肠癌组中的ING1阳性表达率(35.5%)明显低于无血吸虫病结肠癌组(46.4%),结果有统计学意义(P<0.05);而两组中的p53、bcl-2阳性表达率结果无统计学意义(P>0.05)。结论血吸虫病患者的抑癌基因ING1的失活对结肠癌的发生有一定的影响。 Objective To the study relationship between ING1, p53, bcl-2 and colon with schistosemiasis. Methods Envision immunohistochemical method was used to detect the ING1, p53, bcl- 2 expression in 62 cases of carcinoma of colon with schistosemiasis, and 56 cases of carcinoma of colon without schistosemiasis. Results ING1 positivity rate in the two different groups was significant(P 〈 0.05). However, p53, bcl-2 positivity rate in the two groups was insignificant (P 〉 0.05). Conelusion Schistosoma japonicum infection affects the expression of ING1 in carcinoma of colon.
出处 《苏州大学学报(医学版)》 CAS 北大核心 2006年第3期375-377,共3页 Suzhou University Journal of Medical Science
基金 江苏省昆山市科技局2005年社会发展计划项目基金资助(No.KS0526)
关键词 血吸虫病 INGI基因 结肠癌 schistosomiasis ING1 carcinoma of colon
  • 相关文献

参考文献8

  • 1Zhang R, Takahashi S, Orita S, et al. p53 gene mutations in rectal cancer associated with schistosmiasis japonica in Chinese patients [J]. J Cancer Lett, 1998, 131(2):215-221.
  • 2Wahib AA, Masoud AA, Halem AA0 et al. Cell mediated immune response in chronic liver diseases: Schistosomal, viral and neop lastic J [J]. Egypt Soc Parasitol,1998, 28: 929-939.
  • 3Garkavt I, Kazarov A, Gudkov K, et al. Supression of the novel growth inhibtor p33ING1 promotes neoplastic transformation[J]. Nat Genet, 1996, 4:425-420.
  • 4丁厚中,杨栋,吴福荣,李海,冯坤,郑斯杰,倪灿荣,于观贞.胃癌组织中p33^(ING1)基因的表达及突变的检测[J].中华医学杂志,2003,83(4):320-323. 被引量:16
  • 5Warren W, Biggs P J, Stratton M R, et al, Mutations in p53 gene in sehistosomal bladder cancer: a study of 92 turnouts from Egyptiau patients and a comparison between urothelial turnouts[J], Careinogenesls, 1995, 16:1181 - 1189.
  • 6彭雁忠,贾宏,张仁利,邓斌.日本血吸虫所致直肠癌的分子病因学分析[J].中国热带医学,2003,3(2):137-140. 被引量:7
  • 7Watson AJ, Merritt AJ, Jones LS, et al. Evidence for reciprocity of bcl-2 and p53 expression in human colorectal adenomas and carcinomas[J]. Br J Cancer, 1996, 73(8):889 - 895.
  • 8Miyashita T, Krajewshi S. Krajewsha M, et al. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitor and in vivo[J], Oneogene, 1994, 9 (6):1799-1805.

二级参考文献26

  • 1[1]C.C. Harris. p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology and cancer assessment. Science, 1993,262:1980 ~ 1981.
  • 2[2]M. Hollstein, D. Sidransky, V. Bert et al. p53 mutations in human cancer. Science, 1991,253: 49 ~ 53.
  • 3[3]A.J. L evine, J. Momand, C. A. Finlay et al.The p53 tumor suppressor gene.Nature, 1991,351:453 ~ 456.
  • 4[4]B. Bressac, M. Kew, J. Wands, M. Ozturk et al. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature, 1991,350:429 ~ 431.
  • 5[5]I.C.Hsu,R.A.Metcalf, T.Sun et al. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature,350:427 ~ 428.
  • 6[6]P. Khurana, N. Morad, A. R. Khan et al. Impact of schistosomiasis on uninary bladder cancer in the southern province of Saudi Arzbia: review of 60cases. J. Trop. Med. Hyg., 1992,95:149 ~ 151.
  • 7[7]F. B. Alaa, Molecular and geneticevents in schistosomiasis accociated human bladder cancer: role of oncogenes and tumor suppresser genes. Cancer Lett.,1996,105:123 ~ 128.
  • 8[8]Y.lnaba,N.Maruchi,M.Matsuda,N.Yoshihara et al.A case control study on liver cancer with special emphasis. Int. J. Epidemiol, 1984,13: 408 ~ 412.
  • 9[9]B. C.Liu,Z. P. Rong, X. T. Sun et al. Study of geographic correlation between colorectal cancers and schistosomiass in China. Acta Acad. Med. Sci.,1989,5:173 ~ 177.
  • 10[10]IARC working Gruop on the Evaluation of Cacinogenic Risks to Humans,IARC Monographs on the Evaluation of Cacinogenic Risks to Humans, Vol.61. Schistosomes, Liver Flukes and Helicobater pylori. World health organization, Geneva, 1994,45 ~ 100.

共引文献21

同被引文献39

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部